FDA Investigator Matthew F Duff
Matthew F Duff has conducted inspections on 22 sites in 1 countries as of 07 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
22
Last Inspection Date:
07 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Matthew F Duff:
Alan A Rivera,
Ana P Barido,
Bill Tacket, Jr,
CDR Ileana Barreto Pettit,
Chantae D Mitchell,
Claire M Minden,
Craig A Garmendia,
Dianiris C Ayala,
Emily A Baldwin,
Emily A Green,
Jennifer L Huntington,
Jennifer Lalama,
Jennifer M Menendez,
John B Crowe,
Jonathan R Campos,
Karen M Cooper,
Laura L Staples,
LCDR Angelica M Chica,
LT Richard A Lyght,
Marvin D Jones,
Ruth A Williams,
Santos E Camara,
Shari H Shambaugh,
Shari J Hamilton,
Shelby N Turner,
Sheri L Stephenson,
Valerie L Kelesyan,
Victor Spanioli
Matthew F Duff's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2021 | EIR | OPKO Health, Inc. - EIR, 2021-03-01 |
April, 2022 | FDA 483 | Natalia S. Hegedosh, M.D. - Form 483, 2022-04-21 |
January, 2023 | FDA 483 | ECI Pharmaceuticals LLC - Form 483, 2023-01-27 |
October, 2021 | FDA 483 | Olga M. Lapeyra, M.D. - Form 483, 2021-10-25 |
July, 2022 | FDA 483 | Wilfrido A. Benitez, M.D. - Form 483, 2022-07-21 |
September, 2022 | FDA 483 | Yanetsi Flores Landa, M.D. - Form 483, 2022-09-16 |
June, 2022 | FDA 483 | U.S. Investigational Review Board Inc. - Form 483, 2022-06-06 |
October, 2021 | EIR | Olga M. Lapeyra, M.D. - EIR, 2021-10-25 |
September, 2020 | FDA 483 | Ignacio J. Rodriguez, MD - Form 483, 2020-09-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more